Oppenheimer & Co. Inc. boosted its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 8.3% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 24,339 shares of the semiconductor company’s stock after acquiring an additional 1,869 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Synopsys were worth $12,009,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also bought and sold shares of the stock. Vanguard Group Inc. increased its stake in shares of Synopsys by 1.6% in the second quarter. Vanguard Group Inc. now owns 15,060,784 shares of the semiconductor company’s stock worth $7,721,363,000 after buying an additional 231,014 shares during the period. State Street Corp grew its holdings in Synopsys by 1.2% in the 2nd quarter. State Street Corp now owns 7,266,446 shares of the semiconductor company’s stock worth $3,725,362,000 after acquiring an additional 85,662 shares during the last quarter. Geode Capital Management LLC increased its position in shares of Synopsys by 1.5% in the second quarter. Geode Capital Management LLC now owns 3,545,892 shares of the semiconductor company’s stock valued at $1,810,214,000 after acquiring an additional 51,043 shares during the period. Ameriprise Financial Inc. increased its position in shares of Synopsys by 29.1% in the second quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock valued at $1,333,095,000 after acquiring an additional 585,494 shares during the period. Finally, Alliancebernstein L.P. raised its stake in shares of Synopsys by 10.9% during the second quarter. Alliancebernstein L.P. now owns 1,913,001 shares of the semiconductor company’s stock valued at $980,757,000 after acquiring an additional 187,790 shares during the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
SNPS has been the topic of several recent analyst reports. Wall Street Zen raised Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Piper Sandler lowered Synopsys from an “overweight” rating to a “neutral” rating and cut their price objective for the stock from $602.00 to $520.00 in a research report on Tuesday, January 13th. JPMorgan Chase & Co. boosted their target price on Synopsys from $600.00 to $650.00 and gave the company an “overweight” rating in a research note on Thursday, December 11th. Needham & Company LLC raised their price target on Synopsys from $550.00 to $580.00 and gave the stock a “buy” rating in a research note on Thursday, December 11th. Finally, Zacks Research upgraded shares of Synopsys from a “strong sell” rating to a “hold” rating in a report on Monday, November 10th. Nine analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $553.57.
Insider Activity at Synopsys
In related news, insider Janet Lee sold 250 shares of the firm’s stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the transaction, the insider owned 11,959 shares of the company’s stock, valued at $6,338,270. This trade represents a 2.05% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the sale, the chief financial officer directly owned 17,842 shares in the company, valued at $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 4,157 shares of company stock valued at $1,945,036 over the last quarter. Company insiders own 0.62% of the company’s stock.
Synopsys Price Performance
SNPS opened at $438.90 on Tuesday. The company has a current ratio of 1.62, a quick ratio of 1.52 and a debt-to-equity ratio of 0.48. The company has a market cap of $83.97 billion, a price-to-earnings ratio of 54.93, a price-to-earnings-growth ratio of 3.56 and a beta of 1.12. The stock has a fifty day simple moving average of $479.34 and a two-hundred day simple moving average of $493.86. Synopsys, Inc. has a 12-month low of $365.74 and a 12-month high of $651.73.
Synopsys (NASDAQ:SNPS – Get Free Report) last released its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. The firm had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The company’s revenue was up 37.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $3.40 EPS. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Research analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories
- Five stocks we like better than Synopsys
- The buying spree that no one is talking about
- How to collect $500-$800 weekly (BlackRock’s system)
- Trump’s AI Secret: 100X Faster Than Nvidia
- NEW LAW: Congress Approves Setup For Digital Dollar?
- They just tried to kill gold
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
